Adya Saran Sinha

Adya Saran Sinha

Auto-generated profile, based on publicly available information

Adya Saran Sinha

Department of Neurophysiology, Hamamatsu University School of Medicine, Hamamatsu-shi 431-3192, Shizuoka, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Journal of Neuroscience
Verified
Journal Article
Open access
ASAdya Saran Sinha
Adya Saran Sinha
SSSumiya Shibata
Sumiya Shibata
YTYasuyuki Takamatsu
Yasuyuki Takamatsu
TATenpei Akita
Tenpei Akita
AFAtsuo Fukuda
Atsuo Fukuda
TMTatsuya Mima
Tatsuya Mima
Magnetic fields are being used for detailed anatomical and functional examination of the human brain. In addition, evidences for their efficacy in treatment of brain dysfunctions is accumulating. Transcranial static magnetic field stimulation (tSMS) is a recently developed technique for non-invasively modifying brain functions. In tSMS, a strong and small magnet when placed over the skull can temporarily suppress brain functions. Its modulatory effects persist beyond the time of stimulation. However, the neurophysiological mechanisms underlying tSMS-induced plasticity remain unclear. Here, using acute motor cortical slice preparation obtained from male C57BL/6N mice, we show that tSMS alters the intrinsic electrical properties of neurons by altering the activity of chloride (Cl−) channels in neurons. Exposure of mouse pyramidal neurons to a static magnetic field (SMF) at a strength similar to human tSMS, temporarily decreased their excitability and induced transient neuronal swelling. The effects of SMF were blocked by DIDS and GlyH-101, but not by NPPB, consistent with the pharmacological profile of SLC26A11, a transporter protein with Cl−channel activity. Whole-cell voltage-clamp recordings of the GlyH-101-sensitive Cl−current component showed significant enhancement of the component at both subthreshold and depolarized membrane potentials after SMF application, resulting in shunting inhibition and reduced repetitive action potential (AP) firing at the respective potentials. Thus, this study provides the first neurophysiological evidence for the inhibitory effect of tSMS on neuronal activity and advances our mechanistic understanding of non-invasive human neuromodulation.Significance StatementTranscranial static magnetic field stimulation (tSMS) is a recently developed non-invasive brain stimulation technique. In tSMS, a strong, small magnet placed over the skull temporarily suppresses brain functions, and its modulatory effects persist beyond the stimulation time. To elucidate the neurophysiological mechanisms of tSMS, we evaluated the excitability of mouse pyramidal neurons exposed to a static magnetic field at a strength similar to that of human tSMS using whole-cell patch-clamp experiments. We demonstrated that the static magnetic field temporarily decreased neuronal excitability by increasing the activity of a specific type of Cl−channel in the plasma membrane, and it also induced transient neuronal swelling. This study reveals for the first time the neurophysiological mechanism of tSMS-induced suppression of brain functions.

24 October 2023 in Epilepsia
Verified
Journal Article
Open access
TNTrong Dao Nguyen
Trong Dao Nguyen
MIMasaru Ishibashi
Masaru Ishibashi
ASAdya Saran Sinha
Adya Saran Sinha
MWMiho Watanabe
Miho Watanabe
DKDaisuke Kato
Daisuke Kato
AFAtsuo Fukuda
Atsuo Fukuda
Objective: A pathological excitatory action of the major inhibitory neurotransmitter γ‐aminobutyric acid (GABA) has been observed in epilepsy. Blocking the Cl− importer NKCC1 with bumetanide is expected to reduce the neuronal intracellular Cl− concentration ([Cl−]i) and thereby attenuate the excitatory GABA response. Accordingly, several clinical trials of bumetanide for epilepsy were conducted. Although NKCC1 is expressed in both neurons and glial cells, an involvement of glial NKCC1 in seizures has not yet been reported. Astrocytes maintain high [Cl−]i with NKCC1, and this gradient promotes Cl− efflux via the astrocytic GABAA receptor (GABAAR). This Cl− efflux buffers the synaptic cleft Cl− concentration to maintain the postsynaptic Cl− gradient during intense firing of GABAergic neurons, thereby sustaining its inhibitory action during seizure. In this study, we investigated the function of astrocytic NKCC1 in modulating the postsynaptic action of GABA in acute seizure models.Methods: We used the astrocyte‐specific conditional NKCC1 knockout (AstroNKCC1KO) mice. The seizurelike events (SLEs) in CA1 pyramidal neurons were triggered by tetanic stimulation of stratum radiatum in acute hippocampus slices. The SLE underlying GABAAR‐mediated depolarization was evaluated by applying the GABAAR antagonist bicuculline. The pilocarpine‐induced seizure in vivo was monitored in adult mice by the Racine scale. The SLE duration and tetanus stimulation intensity threshold and seizure behavior in AstroNKCC1KO mice and wild‐type (WT) mice were compared.Results: The AstroNKCC1KO mice were prone to seizures with lower threshold and longer duration of SLEs and larger GABAAR‐mediated depolarization underlying the SLEs, accompanied by higher Racine‐scored seizures. Bumetanide reduced these indicators of seizure in AstroNKCC1KO mice (which still express neuronal NKCC1), but not in the WT, both in vitro and in vivo.Significance: Astrocytic NKCC1 inhibits GABA‐mediated excitatory action during seizures, whereas neuronal NKCC1 has the converse effect, suggesting opposing actions of bumetanide on these cells.